Comparative Benchmarking
In the context of the broader market, KZR competes directly with industry leaders such as TIL and SGMO. With a market capitalization of $54.52M, it holds a leading position in the sector. When comparing efficiency, KZR's gross margin of N/A stands against TIL's N/A and SGMO's 100.00%. Such benchmarking helps identify whether Kezar Life Sciences Inc is trading at a premium or discount relative to its financial performance.
